Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Pharmacology

Uncoupling the agony from ecstasy

A mitochondrial protein may mediate a dangerous side-effect of some recreational drugs.

Abstract

The recreational use of amphetamine-type stimulants can produce a marked and sometimes lethal increase in body temperature. Here we show that mice deficient in a mitochondrial protein known as UCP-3 (for 'uncoupling protein-3') have a diminished thermogenic response to the drug MDMA (3,4-methylenedioxymethamphetamine, nicknamed 'ecstasy') and so are protected against this dangerously toxic effect. Our findings indicate that UCP-3 is important in MDMA-induced hyperthermia and point to a new therapeutic direction for solving an increasing public-health problem.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2: Mice deficient in the mitochondrial uncoupling protein UCP-3 (UCP-3−/− mice) are protected against the hyperthermic effects of the drug MDMA.

Similar content being viewed by others

References

  1. Landry, M. J. J. Psychoact. Drugs 34, 163–169 (2002).

    Article  Google Scholar 

  2. Dar, K. J. & McBrien, M. E. Intensive Care Med. 22, 995–996 (1996).

    Article  CAS  Google Scholar 

  3. Lowell, B. B. & Spiegelman, B. M. Nature 404, 652–660 (2000).

    Article  CAS  Google Scholar 

  4. Gong, D.-W. et al. J. Biol. Chem. 275, 16251–16257 (2000).

    Article  CAS  Google Scholar 

  5. Vidal-Puig, A. et al. J. Biol. Chem. 275, 16258–16266 (2000).

    Article  CAS  Google Scholar 

  6. Sprague, J. E., Banks, M. L., Cook, V. J. & Mills, E. M. J. Pharm. Exp. Therap. 305, 159–166 (2003).

    Article  CAS  Google Scholar 

  7. Green, A. R. et al. Pharm. Rev. 55, 463–508 (2003).

    Article  CAS  Google Scholar 

  8. Fantegrossi, W. E. et al. Psychopharmacology 166, 202–211 (2003).

    Article  CAS  Google Scholar 

  9. Echtay, K. S. et al. EMBO J. 16, 4103–4110 (2003).

    Article  Google Scholar 

  10. Halpern, B. N., Drudi-Baracco, C. & Bessirard, D. Nature 204, 387–388 (1964).

    Article  ADS  CAS  Google Scholar 

  11. Gong, D. W., Karas, M. & Reitman, M. J. Biol. Chem. 272, 241129–24132 (1997).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jon E. Sprague.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mills, E., Banks, M., Sprague, J. et al. Uncoupling the agony from ecstasy. Nature 426, 403–404 (2003). https://doi.org/10.1038/426403a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/426403a

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing